Search
CETROTIDE 0.25 MG, Poudre et solvant pour préparation injectable
Details
| --- | Description |
|---|---|
| Pack | Boite de 1 |
| Strength (Dosage) | 0.25 MG |
| Laboratory | PROMOPHARM |
| Ingredients | Cétrorélix |
| Therapeutic class | Antagoniste de la GnRH |
| ATC code | H01CC02 |
| PPH | $25.20 |
| PPV | $38.00 |
| Refundable | Yes |
| Refund base | $38.00 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | Prévention de l’ovulation prématurée chez les patientes incluses dans un protocole de stimulation ovarienne contrôlée, suivie de prélèvement d’ovocytes et de techniques de reproduction assistée. Dans les études cliniques, Cetrotide a été associé à la gonadotrophine de femme ménopausée (HMG). Cependant, l’expérience plus réduite acquise avec l’hormone folliculo-stimulante (FSH) recombinante suggère une efficacité équivalente |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem